This is possible (or the other way around too), but I suspect the reason is the dose of Carfilzomib the mice can handle is just below the threshold that has a measurable effect on the MM cells. If you have a synergistic combination then you can see effects of the combination even at doses below what can be detected when each is used on their own.
I personally find the massive difference between in the in vitro and in vivo efficacy of carfilzomib and bisantrene to be fascinating. In cell culture carfilzomib is more than 100x more effective than bisantrene, but in the mice bisantrene is vastly more effective.
- Forums
- ASX - By Stock
- RAC
- Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model, page-41
-
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.54 |
Change
-0.015(0.97%) |
Mkt cap ! $261.5M |
Open | High | Low | Value | Volume |
$1.55 | $1.55 | $1.50 | $111.4K | 73.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.56 | 1400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.525 |
1 | 828 | 1.505 |
2 | 4000 | 1.490 |
1 | 38500 | 1.480 |
3 | 22244 | 1.450 |
Price($) | Vol. | No. |
---|---|---|
1.555 | 1400 | 1 |
1.640 | 1000 | 1 |
1.650 | 14314 | 2 |
1.690 | 585 | 1 |
1.745 | 12000 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |